• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单纯管状癌和腋窝淋巴结转移。

Pure tubular carcinoma and axillary nodal metastases.

机构信息

Department of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

出版信息

Ann Surg Oncol. 2010 Oct;17 Suppl 3:338-42. doi: 10.1245/s10434-010-1254-2. Epub 2010 Sep 19.

DOI:10.1245/s10434-010-1254-2
PMID:20853056
Abstract

BACKGROUND

Pure tubular carcinoma of the breast is a rare subtype with a low incidence of axillary lymph node metastases. The aim of this study was to determine the frequency of axillary lymph node metastasis in patients with pure tubular carcinoma.

METHODS

We identified patients diagnosed with tubular carcinoma from 1987 to 2009 from our institution's tumor registry. Pathology slides were reviewed, and pure tubular carcinoma was defined as ≥ 90% tubule formation, low nuclear grade, and rare to no mitoses. Medical records were reviewed for clinicopathologic data including tumor size, number of positive and negative axillary lymph nodes, treatment, and recurrence.

RESULTS

We identified 105 cases of pure tubular carcinoma of the breast in 103 patients. Median tumor size was 0.8 (range 0.1-1.8) cm. Nodal staging was performed in 93 cases (89%). Five patients (5.4%) had positive lymph nodes, and two patients (2.2%) had isolated tumor cells. All patients with lymph node metastases had tumors >0.8 cm in size. At 5.2 years' follow-up, no patients have developed recurrence or metastases, or have died from breast cancer.

CONCLUSIONS

Axillary lymph node metastases are not common in small pure tubular carcinomas. Nodal staging may be omitted in small pure tubular carcinomas.

摘要

背景

乳腺单纯管状癌是一种罕见的亚型,腋窝淋巴结转移的发生率较低。本研究旨在确定单纯管状癌患者腋窝淋巴结转移的频率。

方法

我们从我们机构的肿瘤登记处确定了 1987 年至 2009 年诊断为管状癌的患者。对病理切片进行了复查,将单纯管状癌定义为≥90%的小管形成、低核级和罕见或无有丝分裂。回顾了包括肿瘤大小、阳性和阴性腋窝淋巴结数量、治疗和复发在内的临床病理数据的病历。

结果

我们在 103 例患者中确定了 105 例乳腺单纯管状癌。肿瘤大小中位数为 0.8cm(范围 0.1-1.8cm)。93 例(89%)进行了淋巴结分期。5 例(5.4%)患者淋巴结阳性,2 例(2.2%)患者有孤立肿瘤细胞。所有淋巴结转移患者的肿瘤均大于 0.8cm。在 5.2 年的随访中,没有患者出现复发或转移,也没有死于乳腺癌。

结论

在小的单纯管状癌中,腋窝淋巴结转移并不常见。在小的单纯管状癌中可以省略淋巴结分期。

相似文献

1
Pure tubular carcinoma and axillary nodal metastases.单纯管状癌和腋窝淋巴结转移。
Ann Surg Oncol. 2010 Oct;17 Suppl 3:338-42. doi: 10.1245/s10434-010-1254-2. Epub 2010 Sep 19.
2
Is complete axillary lymph node dissection neccessary in T1 stage invasive pure tubular carcinomas of the breast?对于乳腺T1期浸润性纯管状癌,是否有必要进行腋窝淋巴结清扫术?
Breast. 2005 Aug;14(4):325-8. doi: 10.1016/j.breast.2004.12.002.
3
The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields.乳腺癌的淋巴转移模式及其对放射野划定的影响。
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):874-8. doi: 10.1016/j.ijrobp.2004.06.252.
4
Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases.隐匿性乳腺癌伴腋窝转移行乳房切除术的临床获益。
Breast J. 2010 Jan-Feb;16(1):32-7. doi: 10.1111/j.1524-4741.2009.00848.x.
5
Incidence and predictors of axillary metastasis in T1 carcinoma of the breast.T1期乳腺癌腋窝转移的发生率及预测因素
J Am Coll Surg. 1996 Sep;183(3):185-9.
6
The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.导管原位癌和乳腺T1a癌患者淋巴结微转移的发生率及意义。
Eur J Surg Oncol. 2006 Jun;32(5):502-6. doi: 10.1016/j.ejso.2006.02.006. Epub 2006 Mar 29.
7
Probability of axillary node involvement in patients with tubular carcinoma of the breast.乳腺小管癌患者腋窝淋巴结受累的概率。
Br J Surg. 2001 Jun;88(6):860-4. doi: 10.1046/j.0007-1323.2001.01779.x.
8
Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.勘误:前哨淋巴结活检阴性的浸润性乳腺癌腋窝复发率:长期随访。
Ann Surg Oncol. 2010 Feb;17(2):552-7. doi: 10.1245/s10434-009-0800-2.
9
Metachronous secondary primary occult breast cancer initially presenting with metastases to the contralateral axillary lymph nodes: report of a case.同时性双侧隐匿性乳腺癌初始表现为对侧腋窝淋巴结转移:病例报告。
Breast Cancer. 2010;17(1):71-4. doi: 10.1007/s12282-009-0097-9. Epub 2009 Mar 4.
10
Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?对于乳腺癌患者淋巴结受累情况的分期,前哨淋巴结活检是否比腋窝淋巴结清扫更准确?
Chir Ital. 2007 Sep-Oct;59(5):693-9.

引用本文的文献

1
The Relationship Between Clinicopathological Features and Prognosis of 22 Cases of Tubular Breast Carcinoma.22例管状乳腺癌的临床病理特征与预后的关系
Breast J. 2025 Feb 3;2025:5599018. doi: 10.1155/tbj/5599018. eCollection 2025.
2
Evaluation of the efficacy of chemotherapy for tubular carcinoma of the breast: A Surveillance, Epidemiology, and End Results cohort study.评价乳腺癌管状癌化疗的疗效:监测、流行病学和最终结果队列研究。
Cancer Med. 2023 May;12(9):10326-10339. doi: 10.1002/cam4.5763. Epub 2023 Mar 6.
3
Pure and Mixed Tubular Carcinoma of the Breast: Mammographic Features, Clinicopathological Characteristics and Prognostic Analysis.
乳腺单纯型和混合型管状癌:X 线钼靶特征、临床病理特征及预后分析。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211045198. doi: 10.1177/15330338211045198.
4
Clinical Relevance of Tubular Breast Carcinoma: Large Retrospective Study and Meta-Analysis.管状乳腺癌的临床相关性:大型回顾性研究与荟萃分析
Front Oncol. 2021 Apr 29;11:653388. doi: 10.3389/fonc.2021.653388. eCollection 2021.
5
The Role of Axillary Lymph Node Dissection in Tubular Carcinoma of the Breast: A Population Database Study.腋窝淋巴结清扫在乳腺管状癌中的作用:一项基于人群数据库的研究。
Med Sci Monit. 2019 Jan 31;25:880-887. doi: 10.12659/MSM.913077.
6
Clinicopathologic characteristics and clinical outcomes of pure type and mixed type of tubular carcinoma of the breast: a single-institution cohort study.乳腺单纯型和混合型小管癌的临床病理特征及临床结局:一项单机构队列研究
Cancer Manag Res. 2018 Oct 11;10:4509-4515. doi: 10.2147/CMAR.S177046. eCollection 2018.
7
Tubular carcinoma of the breast: clinicopathologic features and survival outcome compared with ductal carcinoma in situ.乳腺管状癌:与导管原位癌的临床病理特征和生存结局比较。
J Breast Cancer. 2013 Dec;16(4):404-9. doi: 10.4048/jbc.2013.16.4.404. Epub 2013 Dec 31.